If a deal is several times oversubscribed, why would anyone walk away from it?
Smart-ring maker Oura postponed its Nasdaq IPO yesterday, the day it was due to price. It had been looking to raise up to $2.2bn, selling 50 million shares at $40-$44 each, implying a fully diluted valuation of circa $15bn. The reason given was "uncertainty in the IPO market", while the company stressed that demand was strong and the business had improved since the process began. Both of those things can be true, but they don't completely explain the decision.
The evidence
Bloomberg reported the book was about 4x covered, and other reporting put it closer to five. But oversubscribed doesn't mean investors were prepared to pay the top of the range.
Also worth noting is who was selling. Of the 50 million shares, only 13.5 million were new stock from Oura. The other 36.5 million came from existing investors, including Forerunner Ventures and Lifeline Ventures. That's important, because when most of an IPO is existing shareholders cashing out, every dollar on the price is their dollar.
Oura isn't desperate for cash. According to its prospectus, at the midpoint of the range most of the net proceeds would have gone towards employees' tax bills on shares vesting, leaving only a small amount for general corporate purposes. So management had a choice: sell now at a price it didn't like, or wait. They chose to wait.
The counterargument
Fair enough. The market does appear to be a tad jumpy. The Fed has hiked, the US 10-year is above 5%, oil remains volatile and investors have become increasingly selective. Oura is also the latest in a run of companies delaying US listings.
I would also argue that Oura can afford to be patient. It's profitable, expects revenue to grow 90% in fiscal 2026 and expects to end the year with around 5.7 million paid members, almost double a year earlier. Walking away is a luxury it can arguably afford.
My read
This wasn't a demand problem. It seems like a price problem, and maybe an anchoring problem.
Oura's last private round, in October 2025, valued the company at around $11bn. The IPO was being pitched materially higher, with a top-end value of ca.$14bn before adjustments. The sellers were likely anchored to that valuation to press the button on an IPO. Whereas buyers are living in a market where cash and bonds are paying around 5%. So, it appears, neither side could agree on what the present value should be.
Underneath all of this was another question: what exactly is Oura? A health-tech company, or a very good consumer gadget company? That description matters enormously. If investors value Oura like health technology, its growth, recurring subscription revenue and health data can support a much higher valuation. If they value it primarily as a wearable device maker, $15bn suddenly looks like a much harder sell.
The Comms Read
"Postponed despite strong demand" is a line that almost answers itself. If demand had been genuinely strong at the price sellers wanted, the deal would have got away.
CEO Tom Hale had a nice line: "We have the luxury of choosing our moment." It reads well and it may even be true. However, say it too confidently and it may become the quote everyone reprints if Oura comes back at a lower price or doesn’t make it on the second attempt.
I would argue that the lesson here is that demand is easy to find. But demand at your price is the only kind of demand that counts.
Also interesting...
Carnival sails through. Record Q3 revenue of ca.$8.4bn and record net income of $1.9bn, both ahead of forecasts. Customer deposits hit a Q3 record, up almost 7% on flat capacity, and bookings for 2027 are already at record prices. People are still paying up for experiences; it's the price of money that's making investors nervous, not the customer.
Micron's $50bn quarter. Micron reports tonight, having guided to $50bn of revenue in a single quarter at an 86% gross margin. That's software-style profitability from a company that makes memory chips. Anything short of a beat-and-raise will test how much of the AI trade is already in the price.
Time will tell. GLA & DYOR.
Disclaimer
This newsletter is published by James Lea / CorpCast for general information, educational and journalistic purposes only. Nothing in it constitutes financial, investment, legal or tax advice, or a personal recommendation, and it is not an offer, invitation or inducement to buy, sell or hold any security, cryptocurrency or other financial instrument.
Any views, opinions, forecasts or interpretations expressed are the author's own personal opinions at the time of publication, do not reflect the views of any business or entity the author is affiliated with, and may change without notice. No account is taken of any reader's personal circumstances, objectives or financial situation, and nothing here should be relied upon as the basis for any investment decision.
The author may from time to time hold long or short positions in securities, cryptocurrencies or other assets referenced in this newsletter, and may transact in them at any time without further notice. This is a standing disclosure covering all issues and is not repeated or itemised per asset.
Investing and trading involve substantial risk of loss, including the potential loss of your entire investment. Past performance is not a reliable indicator of future results. Figures, data and third-party information are believed reliable but are not guaranteed to be accurate, complete or up to date.
James Lea / CorpCast is not authorised or regulated by the Financial Conduct Authority. Always conduct your own independent research and consult a suitably qualified, FCA-regulated financial adviser before making any investment decision.